Interestingly, soluble fms-like tyrosine kinase 1 (a soluble vascular endothelial growth factor receptor), which improved the survival of the CKD–sepsis mice, were ineffective in the septic mice without CKD. This evidence concerns the gene FLT1 and chronic kidney disease.